Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean Follmann

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Contribution of TCR-beta locus and HLA to the shape of the mature human Vbeta repertoireJ Joseph Melenhorst, Matthew D H Lay, David A Price, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2025
Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM SyndromeDavid H McDermott, Shamik Majumdar, Daniel Velez, et al.
Journal of Clinical Immunology|March 29, 2026
Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM SyndromeDavid H McDermott, Shamik Majumdar, Daniel Velez, et al.
Clinical Trials (London, England)|July 18, 2020
Endpoints for randomized controlled clinical trials for COVID-19 treatmentsLori E Dodd, Dean Follmann, Jing Wang, et al.
Journal of Virological Methods|February 27, 2018
Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assayJames Logue, Kaylie Tuznik, Dean Follmann, et al.
Biostatistics (Oxford, England)|June 22, 2025
A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine developmentPeter B Gilbert, James Peng, Larry Han, et al.
Science Translational Medicine|November 29, 2019
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groupsLori E Dodd, Dean Follmann, Michael Proschan, et al.
Annals of Internal Medicine|July 5, 2022
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical TrialDean Follmann, Holly E Janes, Olive D Buhule, et al.
The Journal of Infectious Diseases|April 6, 2005
Compromised B cell responses to influenza vaccination in HIV-infected individualsAngela Malaspina, Susan Moir, Susan M Orsega, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Demographics, Epidemiology, Mortality, and Difficult-To-Treat Resistance Patterns of Bacterial Bloodstream Infections in the Global United States Military Health System from 2010-2019: A Retrospective Cohort StudyAlexander C Vostal, Melissa Grance, John H Powers, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Contribution of TCR-beta locus and HLA to the shape of the mature human Vbeta repertoireJ Joseph Melenhorst, Matthew D H Lay, David A Price, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2025
Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM SyndromeDavid H McDermott, Shamik Majumdar, Daniel Velez, et al.
Journal of Clinical Immunology|March 29, 2026
Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM SyndromeDavid H McDermott, Shamik Majumdar, Daniel Velez, et al.
Clinical Trials (London, England)|July 18, 2020
Endpoints for randomized controlled clinical trials for COVID-19 treatmentsLori E Dodd, Dean Follmann, Jing Wang, et al.
Journal of Virological Methods|February 27, 2018
Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assayJames Logue, Kaylie Tuznik, Dean Follmann, et al.
Biostatistics (Oxford, England)|June 22, 2025
A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine developmentPeter B Gilbert, James Peng, Larry Han, et al.
Science Translational Medicine|November 29, 2019
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groupsLori E Dodd, Dean Follmann, Michael Proschan, et al.
Annals of Internal Medicine|July 5, 2022
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical TrialDean Follmann, Holly E Janes, Olive D Buhule, et al.
The Journal of Infectious Diseases|April 6, 2005
Compromised B cell responses to influenza vaccination in HIV-infected individualsAngela Malaspina, Susan Moir, Susan M Orsega, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Demographics, Epidemiology, Mortality, and Difficult-To-Treat Resistance Patterns of Bacterial Bloodstream Infections in the Global United States Military Health System from 2010-2019: A Retrospective Cohort StudyAlexander C Vostal, Melissa Grance, John H Powers, et al.
Pageof 15